HOME >> MEDICINE >> NEWS
Integrative Cancer Therapies journal accepted into prestigious ISI index

tice or Exercise Intervention? Studying the Benefit for Cancer Survivors"

"Extraction-Dependent Effects of American Ginseng (Panax quinquifolium) on Human Breast Cancer Cell Proliferation and Estrogen Receptor Activation"

Preadministration of High-Dose Salicylates, Suppressors of NF-kB Activation, May Increase the Chemosensitivity of Many Cancers

"Integrative cancer treatment incorporates the best of conventional interventions with meaningful, complementary therapies, and individualizes each patient's care regimen. Treatment plans may include chemotherapy, chronomodulated chemotherapy (circadian-timed chemotherapy), prescriptive exercise, nutritional pharmacology, scientifically tailored supplements, mind/body work and physical therapy," Dr. Block explains. "This acknowledgment by ISI will help professionals and patients alike understand ICT is a forum for disseminating information about groundbreaking and forward-looking work and I congratulate our editorial staff, editorial and advisory boards, and contributors to ICT for this important recognition."


'"/>

Contact: Judy Erickson
media.inquiries@sagepub.com
SAGE Publications
25-Sep-2006


Page: 1 2

Related medicine news :

1. Embargoed materials for Complementary & Integrative Medicine Conference
2. American Cancer Society to hold third annual Virtual Relay For Life in Second Life
3. Cancer research summaries
4. Cancer on the agenda of the Portuguese EU Council Presidency
5. Tony Hunter receives Robert. J. and Claire Pasarow Award for Cancer Research
6. OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients
7. OHSU Cancer Institute, VA researchers find way to identify which men need a second biopsy
8. OHSU Cancer Institute researcher identifies protein marker for prostate cancer survival
9. Ireland Cancer Center researcher lays out benefits of aspirin to prevent colon cancer
10. Mayo Clinic Cancer Center researcher finds mold by-product kills multiple myeloma
11. Margaret Foti receives AACR Award for Leadership and Extraordinary Achievements in Cancer Research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun ... NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is ... is geared towards children of all ages; it is a non-competitive, non-timed event, which ...
(Date:10/13/2017)... VA (PRWEB) , ... October 13, 2017 , ... ... of DevOps and Agile Software Development, has been awarded a contract by the ... Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... ... 12, 2017 , ... Asante, a nationally recognized health system ... their existing home health joint venture through an agreement, effective October 1, 2017, ... venture home health company with Asante, delivering clinically integrated care, for the past ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans ... advance the use of wearable and home sensors for ... disorders. Early Signal Foundation, a nonprofit organization focused on ... will provide an affordable analytical system to record and ... ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology:
Cached News: